You are here

  • Home
  • Archive
  • Volume 13, Issue 7
  • Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

Article metrics

Article menu

Download PDFPDF

Cardiovascular medicine
Protocol
Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial

 

Online download statistics by month:

Online download statistics by month: July 2023 to December 2024

AbstractFullPdf
Jul 202359459391
Aug 202327226744
Sep 202324023751
Oct 202331932027
Nov 202338838729
Dec 202330430232
Jan 2024535221
Feb 2024212116
Mar 2024262633
Apr 2024242317
May 2024424217
Jun 2024282620
Jul 2024363429
Aug 2024323020
Sep 2024271610
Oct 2024252242
Nov 2024272355
Dec 2024001
Total24582421555